Literature DB >> 15383129

A pilot study of visual backward masking performance among affected versus unaffected offspring of parents with bipolar disorder.

Glenda M MacQueen1, Paul Grof, Martin Alda, Michael Marriott, L Trevor Young, Anne Duffy.   

Abstract

BACKGROUND: Cognitive dysfunction is evident in some euthymic patients with established bipolar disorder (BD), including deficits in visual backward masking (VBM) tasks which map to a specific neural pathway. A high-risk paradigm would clarify the temporal relation of cognitive dysfunction to clinical course.
METHOD: We compared euthymic offspring (age range: 18-32 years) of lithium-responsive bipolar parents with and without a previous lifetime history of psychiatric illness to healthy comparison subjects with a negative family history, on a VBM task that requires target location.
RESULTS: High-risk offspring with no lifetime psychiatric history performed the VBM task at levels of healthy controls. High-risk offspring with a previous history of a mood disorder, in complete remission, made significantly more errors at short target-mask intervals than control or never ill offspring. These higher error rates were not a consequence of faster response times.
CONCLUSIONS: There is preliminary evidence of specific cognitive dysfunction early in the course of illness in affected offspring of parents with lithium responsive BD. VBM is ideal for future longitudinal studies addressing whether cognitive dysfunction in BD is a trait marker or a consequence of illness manifestation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15383129     DOI: 10.1111/j.1399-5618.2004.00133.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  14 in total

Review 1.  Neurocognitive function as an endophenotype for genetic studies of bipolar affective disorder.

Authors:  Jonathan B Savitz; Mark Solms; Rajkumar S Ramesar
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Concepts and misconceptions regarding clinical staging models : Author response.

Authors:  Martin Alda; Flavio Kapczinski
Journal:  J Psychiatry Neurosci       Date:  2016-10       Impact factor: 6.186

3.  Fragile early visual percepts mark genetic liability specific to schizophrenia.

Authors:  Scott R Sponheim; Sarah M Sass; Althea L Noukki; Bridget M Hegeman
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

4.  Disturbances of visual motion perception in bipolar disorder.

Authors:  Rebecca A O'Bryan; Colleen A Brenner; William P Hetrick; Brian F O'Donnell
Journal:  Bipolar Disord       Date:  2014-01-02       Impact factor: 6.744

5.  Regional brain activity during early visual perception in unaffected siblings of schizophrenia patients.

Authors:  Junghee Lee; Mark S Cohen; Stephen A Engel; David Glahn; Keith H Nuechterlein; Jonathan K Wynn; Michael F Green
Journal:  Biol Psychiatry       Date:  2010-05-21       Impact factor: 13.382

6.  Neurocognitive functioning in the early stages of bipolar disorder: visual backward masking performance in high risk subjects.

Authors:  Anne Duffy; Tomas Hajek; Martin Alda; Paul Grof; Robert Milin; Glenda MacQueen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-04-23       Impact factor: 5.270

Review 7.  Neurocognitive allied phenotypes for schizophrenia and bipolar disorder.

Authors:  S Kristian Hill; Margret S H Harris; Ellen S Herbener; Mani Pavuluri; John A Sweeney
Journal:  Schizophr Bull       Date:  2008-04-29       Impact factor: 9.306

Review 8.  Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?

Authors:  Anne Duffy; Gin S Malhi; Paul Grof
Journal:  Can J Psychiatry       Date:  2016-07-09       Impact factor: 4.356

9.  The neurocognitive functioning in bipolar disorder: a systematic review of data.

Authors:  Eirini Tsitsipa; Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2015-12-01       Impact factor: 3.455

10.  Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapine.

Authors:  Anne Duffy; Robert Milin; Paul Grof
Journal:  BMC Psychiatry       Date:  2009-02-06       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.